关于举行 2022 年度网上业绩说明会的公告 荣科科技股份有限公司 关于举行 2022 年度网上业绩说明会的公告 本公司及董事会成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 荣科科技股份有限公司（以下简称"公司"）《2022 年年度报告》及其摘要已 于 2023 年 4 月 21 日刊登在巨潮资讯网（http://www.cninfo.com.cn）。 为了让广大投资者进一步了解公司 2022 年的经营情况，公司定于 2023 年 5 月 12 日（星期五）15：00-17：00 在全景网举办 2022 年度网上业绩说明会。本次说明 会将采用网络远程方式举行，投资者可登陆全景网"投资者关系互动平台"（http s://ir.p5w.net）参与本次说明会。 届时，公司董事长郑健先生、独立董事刘爱民先生、财务负责人李绣女士将出 席本次说明会，具体以当天实际参会人员为准。 为充分尊重投资者、提升交流的针对性，现就公司 2022 年度业绩说明会提前向 投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 5 月 11 日（星期四）15：00 前访问 https ...

Financial Performance - The company's revenue for Q1 2023 was CNY 147,900,652.84, representing a 25.43% increase compared to CNY 117,915,538.19 in the same period last year[5] - The net profit attributable to shareholders was a loss of CNY 4,885,716.14, an improvement of 79.02% from a loss of CNY 23,275,506.84 in Q1 2022[5] - Total operating revenue for Q1 2023 was CNY 147.90 million, an increase of 25.4% compared to CNY 117.92 million in the same period last year[17] - The net profit for Q1 2023 was a loss of CNY 2.50 million, an improvement from a loss of CNY 20.74 million in Q1 2022[20] - The company reported a comprehensive loss of CNY 2.50 million for Q1 2023, compared to a comprehensive loss of CNY 20.74 million in the previous year[20] Earnings Per Share - The basic and diluted earnings per share improved to -CNY 0.0076, up 79.18% from -CNY 0.0365 in Q1 2022[5] - Basic and diluted earnings per share for Q1 2023 were both CNY -0.0076, compared to CNY -0.0365 in Q1 2022[20] Cash Flow - The cash flow from operating activities showed a net outflow of CNY 83,123,098.85, which is a 47.64% reduction compared to CNY 158,765,752.43 in the previous year[11] - Cash inflow from operating activities totaled CNY 156.10 million, while cash outflow was CNY 239.22 million in Q1 2023[22] - The net cash flow from investment activities was -2,756,052.52, compared to -11,068,448.56 in the previous year[23] - The total cash outflow from financing activities was 18,665,057.15, down from 45,456,386.37 year-over-year[23] - The net cash flow from financing activities was -16,845,057.15, compared to -38,264,122.19 in the previous year[23] - The net increase in cash and cash equivalents was -102,724,208.52, compared to -208,098,323.18 in the previous year[23] Assets and Liabilities - Total assets at the end of Q1 2023 were CNY 1,461,667,210.86, a decrease of 4.50% from CNY 1,527,160,899.23 at the end of the previous year[5] - Total liabilities decreased from 669,222,985.07 yuan to 602,808,555.05 yuan, a decline of approximately 9.9%[15] - The company’s total assets amounted to CNY 1.46 billion as of the end of Q1 2023[19] - The total equity attributable to shareholders of the parent company was CNY 805.72 million, a decrease from CNY 810.60 million at the end of the previous period[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 25,511[12] - The largest shareholder, Henan Xinchuan Private Equity Fund, holds 19.98% of shares, totaling 128,000,000 shares[12] Financial Expenses and Income - The company reported a significant reduction in financial expenses, down 60.93% to CNY 459,462.35 from CNY 1,176,048.67 in the same quarter last year[9] - Other income increased by 104.07% to CNY 6,055,879.71, primarily due to increased government subsidies[9] - The company recognized investment income of CNY 447,001.70, a turnaround from a loss of CNY 945,862.11 in Q1 2022, marking a 147.26% improvement[9] Inventory and Receivables - Accounts receivable increased from 404,102,877.04 yuan to 425,957,559.70 yuan, reflecting a growth of about 5.4%[14] - Inventory rose from 261,298,961.46 yuan to 271,713,660.12 yuan, indicating an increase of approximately 4.8%[15] Research and Development - Research and development expenses for Q1 2023 were CNY 15.51 million, slightly up from CNY 14.78 million in the same period last year[17] Borrowings - The company’s long-term borrowings increased to CNY 1,080,000.00, reflecting a 100% rise as it had no long-term borrowings at the end of the previous year[8] - The long-term borrowings increased to 1,080,000.00 yuan from zero, indicating the company has taken on new debt[15] Cash and Cash Equivalents - The company's cash and cash equivalents decreased from 290,324,919.07 yuan at the beginning of the year to 187,470,860.13 yuan at the end of the reporting period, a decline of approximately 35.4%[14] - The ending balance of cash and cash equivalents was 184,403,806.77, down from 190,166,288.65 at the end of the previous year[23] - The company’s initial cash and cash equivalents balance was 287,128,015.29, compared to 398,264,611.83 in the previous year[23] Audit Information - The company’s board confirmed that the first quarter report was not audited[23]

Financial Performance - The company reported a significant loss in 2022, with specific reasons and measures for improving profitability detailed in the management discussion section [5]. - The company's operating revenue for 2022 was ¥705,144,082.43, a decrease of 13.72% compared to ¥817,309,721.17 in 2021 [29]. - The net profit attributable to shareholders was -¥225,215,689.00, an improvement of 44.37% from -¥404,820,551.48 in the previous year [29]. - The net cash flow from operating activities reached ¥23,589,710.18, a significant increase of 5,083.00% compared to ¥455,136.20 in 2021 [29]. - The total assets at the end of 2022 were ¥1,527,160,899.23, down 18.54% from ¥1,874,629,684.36 at the end of 2021 [29]. - The net assets attributable to shareholders decreased by 21.86% to ¥810,458,126.05 from ¥1,037,189,051.24 in 2021 [29]. - The basic earnings per share for 2022 was -¥0.3528, an improvement of 46.04% from -¥0.6538 in 2021 [29]. - The weighted average return on equity improved by 8.97 percentage points to -24.47% from -33.44% in 2021 [29]. - The company reported a total revenue of 1.2 billion RMB for 2022, representing a year-over-year increase of 15% [52]. - The company achieved a net profit of 200 million RMB, which is a 10% increase compared to the previous year [52]. Revenue Sources and Trends - Revenue from social security and healthcare increased by 6.92% to ¥443,663,174.69, accounting for 62.92% of total revenue [63]. - Revenue from the government sector decreased by 47.33% to ¥70,371,046.34, representing 9.98% of total revenue [63]. - Revenue from intelligent integrated cloud services dropped by 35.10% to ¥260,511,283.92, making up 36.94% of total revenue [63]. - The Northeast region's revenue fell by 24.49% to ¥291,067,604.09, accounting for 41.28% of total revenue [63]. - The company is experiencing seasonal revenue fluctuations, with significant income typically realized in the fourth quarter [7]. Strategic Initiatives and Investments - The company has increased its investment in product technology to enhance competitiveness and is exploring new service models to improve user engagement and brand value [5]. - The company plans to enhance strategic cooperation with domestic platform manufacturers to promote the localization process and improve product competitiveness [12]. - The company completed acquisitions of 100% of MiJian Information and Shenzhou Shihan, and 80% of Shanghai Jinchang, which will expand its asset scale and business scope [10]. - The company is focusing on talent retention strategies to mitigate risks associated with high-quality talent competition [8]. - The company is committed to domestic innovation, collaborating with major industry groups to meet national requirements in key sectors such as finance and healthcare [49]. Research and Development - The company invested CNY 10,330.72 million in R&D during the reporting period, an increase of 4.22% compared to the previous year [58]. - The company has added 88 new software copyrights during the reporting period, enhancing its intellectual property portfolio [51]. - The company’s R&D investment amounted to ¥103,307,219.16 in 2022, representing 14.65% of its operating revenue, an increase from 12.13% in 2021 [82]. - The number of R&D personnel increased by 3.28% from 305 in 2021 to 315 in 2022, maintaining a stable proportion of 29.17% of total employees [82]. - The company has developed multiple new products, including a health education system and a video conferencing system, aimed at enhancing service quality and increasing revenue [81]. Market Expansion and Future Plans - The company has set a revenue guidance of 1.5 billion RMB for 2023, indicating a growth target of 25% [52]. - Rongke Technology is focusing on expanding its market presence in Southeast Asia, with plans to enter three new countries by the end of 2023 [53]. - The company aims to expand its market presence through innovative product development and strategic partnerships in the healthcare sector [79]. - The company plans to improve operational conditions by enhancing product competitiveness, developing new products and customers, and seeking new profit growth points [117]. - The company is actively pursuing market expansion strategies to enhance its competitive position in the healthcare technology sector [80]. Risk Management and Compliance - The company faces risks related to increased accounts receivable due to sales growth, but it is implementing measures to strengthen management and improve cash flow efficiency [8]. - The company acknowledges risks from market competition and is committed to differentiated innovation in its product offerings [5]. - The company is enhancing its management of goodwill impairment risks associated with its acquisitions [9]. - The company emphasized the importance of internal controls, noting deficiencies related to the aforementioned guarantee [183]. - The company has committed to avoiding competition with its subsidiaries and has issued a letter of commitment to ensure independence post-restructuring [178]. Corporate Governance and Management - The company held a total of 10 board meetings during the reporting period, ensuring compliance with relevant regulations and actively participating in decision-making [125]. - The company established a long-term incentive mechanism to attract and retain talent, aligning the interests of shareholders, the company, and management [125]. - The company maintained independence from its controlling shareholders in terms of assets, personnel, finance, and operations [128]. - The company’s independent directors actively participated in board meetings and provided independent opinions on significant investments and guarantees [125]. - The management team is composed of professionals with significant experience in investment and technology, which may drive future growth strategies [134][135]. Social Responsibility and Sustainability - The company actively promoted employee participation in social responsibility activities, including volunteering and community support [175]. - The company emphasized energy conservation and environmental awareness among employees through various initiatives and internal publications [173]. - In 2022, the company completed a photovoltaic project that generated 45,500 kWh of electricity, saving 17.82 tons of standard coal and reducing carbon emissions by 21.16 tons, equivalent to planting 29 trees [173]. - The company organized fire safety training and emergency management drills in November 2022 to enhance employee safety awareness and ensure safe production [174]. - The company launched a risk identification APP in October 2022, which is available for free to alleviate emergency management pressures in public places [174].

投资者关系活动记录表 证券代码：300290 证券简称：荣科科技 编号：2015-002 | --- | --- | --- | |----------------|----------------------|-----------------------------------------------------------------| | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ | 新闻发布会 □路演活动 | | | □ 现场参观 | | | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及 | 黄斐玉 招商证券 | | | 人员姓名 | | 王庆莉 第一创业证券有限责任公司 | | 时间 | 2015 年 12 | 22 日 14： 00 | | 地点 | 公司会议室 | | | 上市公司接待人 | | 财务总监兼董事会秘书冯丽女士、医疗业务负责人闾海荣先 | | 员姓名 | 生、投资总监张羽先生 | | | | | 首先感谢两位来到荣科，自 2012 年上市以来，荣科积极进行战 | ...

投资者关系活动记录表 证券代码：300290 证券简称：荣科科技 荣科科技股份有限公司投资者关系活动记录表 编号：2015-003 | --- | --- | --- | |----------------|----------------------|-------------------------------------------------------------------| | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ | 新闻发布会 □路演活动 | | | □ 现场参观 | | | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及 | 宋彬 中银国际证券 | | | 人员姓名 | 杨祺 新华基金 | | | 时间 | 2015 年 12 | 28 日 14： 00 | | 地点 | 公司会议室 | | | 上市公司接待人 | | 财务总监兼董事会秘书冯丽女士、医疗业务负责人闾海荣先 | | 员姓名 | 生、投资总监张羽先生 | | | | | 一、介绍公司智慧医疗发展战略及规划 | ...

投资者关系活动记录表 证券代码：300290 证券简称：荣科科技 编号：2015-001 | --- | --- | --- | |----------|------------------------|------------------------------------------------------------------| | | | | | | □ | 特定对象调研 □分析师会议 | | 投资者关 | □ | 媒体采访 □业绩说明会 | | 系活动类 | □ 新闻发布会 □路演活动 | | | 别 | □ 现场参观 | | | | √ 其他 （战略发布会） | | | 参与单位 | | 方正富邦基金 高松、东北证券 吴雁 许祥、海通资管 童胜、民生证券 | | 名称及人 | | 马松、中金基金 郭党钰、东岭投资 王顺欢、中金公司 张景松、齐鲁资 | | 员姓名 | | 管 应晓晨、达仁资管 杨尚烨、国联安基金 郑青、中银基金 刘潇、敦和 | | | | 资管 安昀 黄国珍、长江养老保险 邓锐、国金自营 袁艺博、国泰基金 | | | | 刘健维、东吴基金 朱冰兵、从容投资 沈磊、本翼资本 金麟凤 ...

投资者关系活动记录表 证券代码：300290 证券简称：荣科科技 荣科科技股份有限公司投资者关系活动记录表 编号：2016-002 | --- | --- | --- | |-----------------------|------------------------|--------------------------------------------------------------| | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及 | 铭基国际投资公司 祝泉 | | | 人员姓名 | | | | 时间 | 2016 年 2 月 4 | 日 14： 00 | | 地点 上市公司接待人 | 公司会议室 | | | 员姓名 | | 财务总监兼董事会秘书冯丽女士、投资总监张羽先生 | | 投资者关系活动 | | 一、介绍公司智慧医疗发展战略及规划 | | | 二、交流环节 | | ...

投资者关系活动记录表 证券代码：300290 证券简称：荣科科技 荣科科技股份有限公司投资者关系活动记录表 编号：2016-003 | --- | --- | --- | |----------------|------------------------------------|--------------------------------------------------------------| | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及 | 海通证券股份有限公司 王鸣阳 | | | 人员姓名 | | | | 时间 | 2016 年 11 月 21 | 日 15： 00 | | 地点 | 公司会议室 | | | 上市公司接待人 | | | | 员姓名 | | 财务总监兼董事会秘书冯丽女士、投资总监张羽先生 | | 投资者关系活动 | 一、介绍公司智慧医疗发展战略及规划 | ...